Virtual Medicinal Product (VMP)
-
Rasburicase 7.5mg powder and solvent for solution for infusion vials
Name Details
Current Name
Rasburicase 7.5mg powder and solvent for solution for infusion vials
|
Start Date
14-01-2009
|
End Date
|
Previous Name
Rasburicase 7.5mg powder and solvent for solution for injection vials
|
Start Date
11-06-2004
|
End Date
13-01-2009
|
|
Abbreviated Name
Rasburicase 7.5mg inf vials
|
Start Date
14-01-2009
|
|
Rasburicase 7.5mg pdr & solv for soln for inj vials |
Previous Start Date
14-09-2004
|
Previous End Date
13-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder and solvent for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
V03AF07
BNF |
Current BNF
10010400
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
10010400
|
Start Date
21-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
4848111000001100 |
04-09-2003 |
|
VMP Ingredients
VMP ingredients table
Rasburicase |
Based on Ingredient Substance |
|
7.5 mg |
|
Name
Rasburicase
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
7.5
Strength and UOM (Dmr)
Parent Products
-
VTM
Rasburicase
-
VMP
(Current) Rasburicase 7.5mg powder and solvent...
Virtual Medicinal Product Pack (VMPP) Information